NYSE - Delayed Quote USD

Avanos Medical, Inc. (AVNS)

18.71 -0.05 (-0.27%)
At close: April 24 at 4:00 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Joseph F. Woody CEO & Director 2.21M -- 1966
Mr. Michael C. Greiner Senior VP, CFO & Chief Transformation Officer 986.42k -- 1973
Ms. Mojirade James Senior VP, General Counsel & Corporate Secretary 728.66k -- 1967
Mr. Kerr W. Holbrook Senior VP & Chief Commercial Officer 747.61k -- 1967
Mr. John Joseph Hurley Principal Accounting Officer & Controller -- -- --
Mr. David Crawford VP of FP&A and Investor Relations and Treasurer -- -- --
Ms. Michelle Scharfenberg Senior VP and Chief Ethics & Compliance Officer -- -- --
Mr. Scott Galovan Vice President of Strategy & Corporate Development -- -- --
John W. Cato Vice President of Human Resources -- -- --
Mr. Lee Burnes Senior Vice President of Global R&D, Clinical and Medical Affairs -- -- --

Avanos Medical, Inc.

5405 Windward Parkway
Suite 100 South
Alpharetta, GA 30004
United States
844 428 2667 https://avanos.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
3,771

Description

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Corporate Governance

Avanos Medical, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 3. The pillar scores are Audit: 5; Board: 1; Shareholder Rights: 7; Compensation: 2.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 01, 2024 - May 06, 2024
Avanos Medical, Inc. Earnings Call

Related Tickers